Novartis announced that it condemns the war in Ukraine: “The continued acts of unprovoked violence are harming innocent people, and this defies our mission to improve hum… Detailed results from the PROVENT Phase III pre-exposure prophylaxis (prevention) trial showed that AstraZeneca’s Evusheld (tixagevimab and cilgavimab), formerly AZD7442… Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding […]
Source
This post first appeared on Fav Store – Herbal Products And News, please read the originial post: here